BACKGROUND: Mini gastric bypass is thought to have  a major role in the rapid improvement  in glycemic control of Type 2 diabetes  patient OBJECTIVE: The goal of this study was to determine the effect of MGB on T2D remission in obese and morbidly obese patients. METHODS: The present study was conducted in a single center – Saraswathy  Hospital, Thiruvanthapuram , India, with the data collected prospectively and analyzed retrospectively. The study group consisted of all patients with T2D who underwent MGB from  January 2010 to December   2016 and had at least 1 month of follow–up. An informed consent was obtained from all the patients. T2D patients with a BMI of ≥ 31 kg/m2 were offered MGB after failure of conservative treatment, following complete evaluation by a multi–disciplinary team RESULTS: MGB had a marked effect on T2D. HbA1c markedly improved or returned to normal. Out of 17 patients, 15  patients achieved HbA1c levels between 6.4  and 5.2% without anti–diabetic medicine,98 %  patients stopped complete medication  2 % patients switched  on from multiple  anti diabetic medications to single oral diabetic medication   CONCLUSION: MGB results in sustained weight loss and significant improvement in blood sugar  control, leading to clinical improvement in T2D and its related complications.there fore  Type 2 Diabetes in obese patient can be controlled with this MGB